The corporation claimed that 3Cnet is the 1st recurrent neural network-centered pathogenicity prediction Device that evaluates the effects of variants from the context of protein sequences. The corporate started out by giving complete-exome sequencing for diagnostics but additional total-genome sequencing in late 2020 in hopes of improving the d